Endomyocardial biopsy should be used to assess the following conditions |
---|
(1) Allograft heart rejection surveillance |
(2) Myocarditis |
(3) Amyloidosis |
(4) Haemochromatosis |
(5) Sarcoidosis |
(6) Fabry’s disease |
(7) Loeffler’s endomyocarditis |
(8) Mastocytosis |
(9) Neoplasia (benign, primary malignant, or metastatic) |
(10) Cardiomyopathies (hypertrophic, dilated, or restrictive) |
(11) Drug toxicity (for example, Adriamycin, Herceptin) |
(12) Arrhythmia |
(13) Unexplained chest pain |
(14) Unexplained congestive heart failure |
(15) Differentiation between restriction and pericardial constriction |